Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients

Abstract Background Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) often develop hypertension in childhood or early adulthood. Although this could result in left ventricular hypertrophy (LVH), a major risk factor for cardiovascular morbidity and mortality, prior studies of LVH in...

Full description

Bibliographic Details
Main Authors: Huanwen Chen, Terry Watnick, Susie N. Hong, Barry Daly, Yongfang Li, Stephen L. Seliger
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Nephrology
Online Access:http://link.springer.com/article/10.1186/s12882-019-1555-z
id doaj-ef22203ea5324726a95d23eb179ddd95
record_format Article
spelling doaj-ef22203ea5324726a95d23eb179ddd952020-11-25T04:00:18ZengBMCBMC Nephrology1471-23692019-10-0120111010.1186/s12882-019-1555-zLeft ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patientsHuanwen Chen0Terry Watnick1Susie N. Hong2Barry Daly3Yongfang Li4Stephen L. Seliger5Division of Nephrology, University of Maryland School of MedicineDivision of Nephrology, University of Maryland School of MedicineDivision of Cardiology, University of Maryland School of MedicineDepartment of Diagnostic Radiology, University of Maryland School of MedicineDivision of Cardiology, University of Maryland School of MedicineDivision of Nephrology, University of Maryland School of MedicineAbstract Background Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) often develop hypertension in childhood or early adulthood. Although this could result in left ventricular hypertrophy (LVH), a major risk factor for cardiovascular morbidity and mortality, prior studies of LVH in ADPKD have yielded conflicting results. We estimated the prevalence of LVH using consensus echocardiography criteria and examined the independent association of ADPKD severity with LV mass in a contemporary cohort of ADPKD patients. Methods Adults with ADPKD and eGFR> 15 ml/min/1.73m2 were enrolled in a single-center study. Left Ventricular Mass (LVM) was quantified using 2D echocardiography, and LVH was defined using gender-specific cut-points of LVM and LVM indexed to body surface area (LVMI) from consensus guidelines. Total Kidney Volume (TKV) was quantified using Magnetic Resonance Imaging, and GFR was estimated from serum creatinine using the CKD-Epi equation. Multiple linear regression was used to estimate the association of TKV and eGFR with LVM and LVMI, adjusting for potential confounders. Results Among 126 participants (78% with hypertension), median age was 46 years, median eGFR 63 ml/min/1.73 m2, and median [IQR] systolic blood pressure was 125 [116–133] mmHg. Prevalence of LVH was 21.4% as defined by LVMI and was not significantly different (p = 0.8) between those with and without HTN, and was similar (21.4%) after excluding those (N = 21) with known cardiac disease. Greater TKV and lower eGFR were directly correlated with greater LVMI (p = .016 and p < .001, respectively). In multiple linear regression models accounting for potential confounders including blood pressure, greater TKV was positively associated with LVM ( β̂ $$ \hat{\beta} $$ =0.19, p = 0.04). Conclusions In a contemporary cohort of ADPKD patients with well-controlled blood pressure, the prevalence of LVH is high, and ADPKD severity as reflected by TKV is independently associated with greater LV mass. These results may suggest a relationship between ADPKD pathophysiology and increased LV mass.http://link.springer.com/article/10.1186/s12882-019-1555-z
collection DOAJ
language English
format Article
sources DOAJ
author Huanwen Chen
Terry Watnick
Susie N. Hong
Barry Daly
Yongfang Li
Stephen L. Seliger
spellingShingle Huanwen Chen
Terry Watnick
Susie N. Hong
Barry Daly
Yongfang Li
Stephen L. Seliger
Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients
BMC Nephrology
author_facet Huanwen Chen
Terry Watnick
Susie N. Hong
Barry Daly
Yongfang Li
Stephen L. Seliger
author_sort Huanwen Chen
title Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients
title_short Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients
title_full Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients
title_fullStr Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients
title_full_unstemmed Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients
title_sort left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients
publisher BMC
series BMC Nephrology
issn 1471-2369
publishDate 2019-10-01
description Abstract Background Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) often develop hypertension in childhood or early adulthood. Although this could result in left ventricular hypertrophy (LVH), a major risk factor for cardiovascular morbidity and mortality, prior studies of LVH in ADPKD have yielded conflicting results. We estimated the prevalence of LVH using consensus echocardiography criteria and examined the independent association of ADPKD severity with LV mass in a contemporary cohort of ADPKD patients. Methods Adults with ADPKD and eGFR> 15 ml/min/1.73m2 were enrolled in a single-center study. Left Ventricular Mass (LVM) was quantified using 2D echocardiography, and LVH was defined using gender-specific cut-points of LVM and LVM indexed to body surface area (LVMI) from consensus guidelines. Total Kidney Volume (TKV) was quantified using Magnetic Resonance Imaging, and GFR was estimated from serum creatinine using the CKD-Epi equation. Multiple linear regression was used to estimate the association of TKV and eGFR with LVM and LVMI, adjusting for potential confounders. Results Among 126 participants (78% with hypertension), median age was 46 years, median eGFR 63 ml/min/1.73 m2, and median [IQR] systolic blood pressure was 125 [116–133] mmHg. Prevalence of LVH was 21.4% as defined by LVMI and was not significantly different (p = 0.8) between those with and without HTN, and was similar (21.4%) after excluding those (N = 21) with known cardiac disease. Greater TKV and lower eGFR were directly correlated with greater LVMI (p = .016 and p < .001, respectively). In multiple linear regression models accounting for potential confounders including blood pressure, greater TKV was positively associated with LVM ( β̂ $$ \hat{\beta} $$ =0.19, p = 0.04). Conclusions In a contemporary cohort of ADPKD patients with well-controlled blood pressure, the prevalence of LVH is high, and ADPKD severity as reflected by TKV is independently associated with greater LV mass. These results may suggest a relationship between ADPKD pathophysiology and increased LV mass.
url http://link.springer.com/article/10.1186/s12882-019-1555-z
work_keys_str_mv AT huanwenchen leftventricularhypertrophyinacontemporarycohortofautosomaldominantpolycystickidneydiseasepatients
AT terrywatnick leftventricularhypertrophyinacontemporarycohortofautosomaldominantpolycystickidneydiseasepatients
AT susienhong leftventricularhypertrophyinacontemporarycohortofautosomaldominantpolycystickidneydiseasepatients
AT barrydaly leftventricularhypertrophyinacontemporarycohortofautosomaldominantpolycystickidneydiseasepatients
AT yongfangli leftventricularhypertrophyinacontemporarycohortofautosomaldominantpolycystickidneydiseasepatients
AT stephenlseliger leftventricularhypertrophyinacontemporarycohortofautosomaldominantpolycystickidneydiseasepatients
_version_ 1724451439281963008